AngioDynamics (ANGO) Upgraded by Canaccord Genuity to Buy

AngioDynamics} stock has undergone multiple analysts rating changes in the recent past.  AngioDynamics Upgraded by Canaccord Genuity on 10/15/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More AngioDynamics (ANGO) Upgraded by Canaccord Genuity to Buy